Cardano Risk Management B.V. has opened a new $103.5M position in $ABBV, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $ABBV.
$ABBV Hedge Fund Activity
We have seen 1,701 institutional investors add shares of $ABBV stock to their portfolio, and 1,697 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 10,182,211 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $1,890,022,005
- CAPITAL INTERNATIONAL INVESTORS removed 7,996,758 shares (-28.0%) from their portfolio in Q1 2025, for an estimated $1,675,480,736
- FMR LLC added 5,539,207 shares (+30.6%) to their portfolio in Q1 2025, for an estimated $1,160,574,650
- BLACKROCK, INC. added 3,842,577 shares (+2.7%) to their portfolio in Q1 2025, for an estimated $805,096,733
- ASSENAGON ASSET MANAGEMENT S.A. added 3,666,521 shares (+550.9%) to their portfolio in Q2 2025, for an estimated $680,579,628
- GOLDMAN SACHS GROUP INC added 3,351,687 shares (+29.7%) to their portfolio in Q1 2025, for an estimated $702,245,460
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 3,134,454 shares (+inf%) to their portfolio in Q2 2025, for an estimated $581,817,351
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABBV Insider Trading Activity
$ABBV insiders have traded $ABBV stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- TIMOTHY J. RICHMOND (EVP, CHIEF HR OFFICER) has made 0 purchases and 6 sales selling 29,917 shares for an estimated $6,070,036.
- KEVIN K BUCKBEE (SVP, CONTROLLER) has made 0 purchases and 2 sales selling 18,944 shares for an estimated $3,853,372.
- SCOTT T REENTS (EVP, CHIEF FINANCIAL OFFICER) sold 17,644 shares for an estimated $3,746,526
- PERRY C SIATIS (EVP, GC AND SECRETARY) has made 0 purchases and 2 sales selling 5,778 shares for an estimated $1,143,452.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABBV Government Contracts
We have seen $526,017 of award payments to $ABBV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANTS: $36,934
- IMPLANT: $35,788
- 4567253744!NATRELLE TE SMOOTH 133S-SV-13-T: $33,629
- IMPLANTS: $29,604
- PROSTHETICS:SURGICAL IMPLANTS BREAST RECONSTRUCTION: $29,513
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$ABBV Congressional Stock Trading
Members of Congress have traded $ABBV stock 13 times in the past 6 months. Of those trades, 9 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 4 times. They made 3 purchases worth up to $45,000 on 05/22, 04/03, 04/01 and 1 sale worth up to $15,000 on 04/17.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/15, 02/25 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/05, 03/17 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $100,000 on 02/24 and 1 sale worth up to $100,000 on 04/17.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 04/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABBV Analyst Ratings
Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 04/29/2025
- Evercore ISI Group issued a "Outperform" rating on 04/28/2025
- Raymond James issued a "Outperform" rating on 04/28/2025
- Morgan Stanley issued a "Overweight" rating on 04/28/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/22/2025
- Wells Fargo issued a "Overweight" rating on 03/05/2025
- BMO Capital issued a "Outperform" rating on 02/03/2025
To track analyst ratings and price targets for $ABBV, check out Quiver Quantitative's $ABBV forecast page.
$ABBV Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 12 analysts offer price targets for $ABBV in the last 6 months, with a median target of $215.5.
Here are some recent targets:
- Geoff Meacham from Citigroup set a target price of $205.0 on 05/14/2025
- Vamil Divan from Guggenheim set a target price of $216.0 on 04/29/2025
- Gary Nachman from Raymond James set a target price of $227.0 on 04/28/2025
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $205.0 on 04/28/2025
- Terence Flynn from Morgan Stanley set a target price of $250.0 on 04/28/2025
- Carter Gould from Cantor Fitzgerald set a target price of $210.0 on 04/22/2025
- Asad Haider from Goldman Sachs set a target price of $194.0 on 04/08/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $ABBV ticker page for more data.
